Talc
Sclerosol, Steritalc, Talc (talc) is a small molecule pharmaceutical. Talc was first approved as Sclerosol on 1997-12-24. It is used to treat pleural effusion and pneumothorax in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| respiratory tract diseases | D012140 |
Trade Name
FDA
EMA
Sclerosol, Steritalc, Talc
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Talc
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| STERITALC | Novatech | N-205555 RX | 2017-05-01 | 3 products, RLD, RS |
| SCLEROSOL | Sciarra Laboratories | N-020587 RX | 1997-12-24 | 1 products, RLD, RS |
| TALC | Sciarra Laboratories | N-021388 RX | 2003-12-15 | 1 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| baby | OTC monograph not final | 2020-08-13 |
| dr. waltons | OTC monograph not final | 2012-02-21 |
| face it hd perfect bb spf30 pa 01 | OTC monograph not final | 2011-08-23 |
| face it hd perfect bb spf30 pa 02 | OTC monograph not final | 2011-08-23 |
| health smart baby | OTC monograph not final | 2020-08-13 |
| menthol | C200263 | 2024-02-13 |
| miconazole nitrate | C200263 | 2024-11-01 |
| mineral wear talc free mineral face powder | OTC monograph not final | 2023-01-24 |
| mineral wear talc-free mineral airbrushing blush | OTC monograph final | 2012-11-15 |
| natures choice baby | OTC monograph not final | 2016-06-13 |
Show 12 more
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| pleural effusion | HP_0002202 | D010996 | J90 |
| pneumothorax | HP_0002108 | D011030 | J93.11 |
Agency Specific
FDA
EMA
Expiration | Code | ||
|---|---|---|---|
TALC, STERITALC, NOVATECH SA | |||
| 2024-05-01 | ODE-143, ODE-191 | ||
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
87 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pleural effusion | D010996 | HP_0002202 | J90 | 1 | 2 | 5 | 2 | 10 | 20 |
| Malignant pleural effusion | D016066 | — | J91.0 | 1 | 2 | 5 | 2 | 10 | 20 |
| Disease progression | D018450 | — | — | — | — | — | 1 | 1 | 2 |
| Hyperlipidemias | D006949 | HP_0003077 | E78.5 | 1 | 1 | — | 1 | — | 2 |
| Pancreaticoduodenectomy | D016577 | — | — | — | — | — | 1 | — | 1 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | — | 1 | — | 1 |
| Fibrosis | D005355 | — | — | — | — | — | 1 | — | 1 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | 1 | — | 1 |
| Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | — | — | — | 1 | — | 1 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | — | — | 1 | — | 1 |
Show 3 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | — | — | 4 | — | 2 | 6 |
| Syndrome | D013577 | — | — | 1 | — | 2 | — | 1 | 4 |
| Mesothelioma | D008654 | — | C45 | — | 1 | 2 | — | 1 | 4 |
| Covid-19 | D000086382 | — | — | — | — | 3 | — | — | 3 |
| Malignant mesothelioma | D000086002 | — | — | — | 1 | 1 | — | 1 | 3 |
| Lung neoplasms | D008175 | HP_0100526 | C34.90 | 2 | — | 1 | — | — | 3 |
| Asthma | D001249 | EFO_0000270 | J45 | — | — | 1 | — | 1 | 2 |
| Endometrial neoplasms | D016889 | EFO_0004230 | — | — | 1 | 1 | — | — | 2 |
| Chondrocalcinosis | D002805 | HP_0000934 | M11.2 | — | — | 1 | — | — | 1 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | 1 | — | — | 1 |
Show 6 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pneumothorax | D011030 | HP_0002108 | J93.11 | 1 | 1 | — | — | 2 | 3 |
| Myelodysplastic syndromes | D009190 | — | D46 | — | 1 | — | — | 1 | 2 |
| Myelomonocytic leukemia chronic | D015477 | — | C93.1 | — | 1 | — | — | 1 | 2 |
| Myelomonocytic leukemia juvenile | D054429 | — | C93.3 | — | 1 | — | — | 1 | 2 |
| Chronic periodontitis | D055113 | EFO_0006343 | K05.3 | — | 2 | — | — | — | 2 |
| Periodontitis | D010518 | EFO_0000649 | K05.3 | — | 2 | — | — | — | 2 |
| Inflammation | D007249 | MP_0001845 | — | 1 | 1 | — | — | 1 | 2 |
| Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | — | 1 | — | — | 1 | 2 |
| Leukemia | D007938 | — | C95 | — | 1 | — | — | — | 1 |
| Myeloid leukemia acute | D015470 | — | C92.0 | — | 1 | — | — | — | 1 |
Show 24 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 2 | — | — | — | 1 | 3 |
| Hiv | D006678 | — | — | 1 | — | — | — | — | 1 |
| Medication adherence | D055118 | EFO_0006344 | — | 1 | — | — | — | — | 1 |
| Non-small-cell lung carcinoma | D002289 | — | — | 1 | — | — | — | — | 1 |
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | 1 | — | — | — | — | 1 |
| Colitis | D003092 | EFO_0003872 | K52.9 | 1 | — | — | — | — | 1 |
| Ulcer | D014456 | MPATH_579 | — | 1 | — | — | — | — | 1 |
| Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | 1 | — | — | — | — | 1 |
| Diarrhea | D003967 | HP_0002014 | R19.7 | 1 | — | — | — | — | 1 |
| Urinary incontinence | D014549 | HP_0000020 | R32 | 1 | — | — | — | — | 1 |
Show 3 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Celiac disease | D002446 | EFO_0001060 | K90.0 | — | — | — | — | 2 | 2 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 1 | 1 |
| Gestational diabetes | D016640 | HP_0009800 | O24.4 | — | — | — | — | 1 | 1 |
| Pregnancy in diabetics | D011254 | — | O24.91 | — | — | — | — | 1 | 1 |
| Endometriosis | D004715 | EFO_0001065 | N80 | — | — | — | — | 1 | 1 |
| Pleural diseases | D010995 | — | — | — | — | — | — | 1 | 1 |
| Vitamin d deficiency | D014808 | EFO_0003762 | E55 | — | — | — | — | 1 | 1 |
| Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | — | — | 1 | 1 |
| Premenstrual syndrome | D011293 | — | N94.3 | — | — | — | — | 1 | 1 |
| Hiv infections | D015658 | EFO_0000764 | B20 | — | — | — | — | 1 | 1 |
Show 20 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Talc |
| INN | — |
| Description | Talc is a mineral composed of magnesium silicate.
|
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | O.O=[Mg].O=[Mg].O=[Mg].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O |
Identifiers
| PDB | — |
| CAS-ID | 14807-96-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL3989756 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 9,742 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
798 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use